Cargando…
Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys
The purpose of this study was to investigate the clinical application of intensity-modulated radiotherapy combined with intracavitary radiotherapy for locally advanced cervical cancer complicated with uterus didelphys. We retrospectively reviewed the medical records of six patients with locally adva...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909386/ https://www.ncbi.nlm.nih.gov/pubmed/33718560 http://dx.doi.org/10.1016/j.gore.2021.100724 |
_version_ | 1783655919537618944 |
---|---|
author | Lei, Chengzhi Huang, Manni Li, Ning An, Jusheng Xiong, Suiyang Xu, Yingjie |
author_facet | Lei, Chengzhi Huang, Manni Li, Ning An, Jusheng Xiong, Suiyang Xu, Yingjie |
author_sort | Lei, Chengzhi |
collection | PubMed |
description | The purpose of this study was to investigate the clinical application of intensity-modulated radiotherapy combined with intracavitary radiotherapy for locally advanced cervical cancer complicated with uterus didelphys. We retrospectively reviewed the medical records of six patients with locally advanced cervical cancer associated with uterine malformations treated at the National Cancer Center/Cancer Hospital (Beijing, China) between 2015 and 2018. Six cases, including cervical squamous cell carcinoma (n = 3), cervical adenocarcinoma (n = 2), and clear cell adenocarcinoma (n = 1) were identified by pathological diagnosis. Uterine malformation included uterus didelphys (n = 6), with vaginal subseptum (n = 2). Six cases were treated with pelvic intensity-modulated radiotherapy. Four patients received three- dimensional intracavitary brachytherapy based on computed tomography, and two patients received conventional two-dimensional intracavitary brachytherapy. The acute and delayed responses of gastrointestinal and genitourinary toxicities were ≤grade 2 in 5 patients. Five patients achieved clinical complete remission and four patients had no recurrence during the follow-up period. One patient with cervical adenocarcinoma expired due to progression of the disease. The clinical results suggest that advanced cervical cancer associated with uterus didelphys required individual radiotherapy. The use of intensity-modulated radiotherapy combined with three-dimensional intracavitary brachytherapy is recommended in concurrent chemoradiotherapy. |
format | Online Article Text |
id | pubmed-7909386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-79093862021-03-12 Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys Lei, Chengzhi Huang, Manni Li, Ning An, Jusheng Xiong, Suiyang Xu, Yingjie Gynecol Oncol Rep Research Report The purpose of this study was to investigate the clinical application of intensity-modulated radiotherapy combined with intracavitary radiotherapy for locally advanced cervical cancer complicated with uterus didelphys. We retrospectively reviewed the medical records of six patients with locally advanced cervical cancer associated with uterine malformations treated at the National Cancer Center/Cancer Hospital (Beijing, China) between 2015 and 2018. Six cases, including cervical squamous cell carcinoma (n = 3), cervical adenocarcinoma (n = 2), and clear cell adenocarcinoma (n = 1) were identified by pathological diagnosis. Uterine malformation included uterus didelphys (n = 6), with vaginal subseptum (n = 2). Six cases were treated with pelvic intensity-modulated radiotherapy. Four patients received three- dimensional intracavitary brachytherapy based on computed tomography, and two patients received conventional two-dimensional intracavitary brachytherapy. The acute and delayed responses of gastrointestinal and genitourinary toxicities were ≤grade 2 in 5 patients. Five patients achieved clinical complete remission and four patients had no recurrence during the follow-up period. One patient with cervical adenocarcinoma expired due to progression of the disease. The clinical results suggest that advanced cervical cancer associated with uterus didelphys required individual radiotherapy. The use of intensity-modulated radiotherapy combined with three-dimensional intracavitary brachytherapy is recommended in concurrent chemoradiotherapy. Elsevier 2021-02-08 /pmc/articles/PMC7909386/ /pubmed/33718560 http://dx.doi.org/10.1016/j.gore.2021.100724 Text en © 2021 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Report Lei, Chengzhi Huang, Manni Li, Ning An, Jusheng Xiong, Suiyang Xu, Yingjie Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys |
title | Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys |
title_full | Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys |
title_fullStr | Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys |
title_full_unstemmed | Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys |
title_short | Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys |
title_sort | intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys |
topic | Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909386/ https://www.ncbi.nlm.nih.gov/pubmed/33718560 http://dx.doi.org/10.1016/j.gore.2021.100724 |
work_keys_str_mv | AT leichengzhi intensitymodulatedradiotherapycombinedwithintracavitarybrachytherapyforlocallyadvancedcervicalcancerwithuterusdidelphys AT huangmanni intensitymodulatedradiotherapycombinedwithintracavitarybrachytherapyforlocallyadvancedcervicalcancerwithuterusdidelphys AT lining intensitymodulatedradiotherapycombinedwithintracavitarybrachytherapyforlocallyadvancedcervicalcancerwithuterusdidelphys AT anjusheng intensitymodulatedradiotherapycombinedwithintracavitarybrachytherapyforlocallyadvancedcervicalcancerwithuterusdidelphys AT xiongsuiyang intensitymodulatedradiotherapycombinedwithintracavitarybrachytherapyforlocallyadvancedcervicalcancerwithuterusdidelphys AT xuyingjie intensitymodulatedradiotherapycombinedwithintracavitarybrachytherapyforlocallyadvancedcervicalcancerwithuterusdidelphys |